c src kinase inhibitor pp2 (Selleck Chemicals)
Selleck Chemicals is a verified supplier 
Selleck Chemicals manufactures this product 
95
Structured Review
Selleck Chemicals
c src kinase inhibitor pp2
C Src Kinase Inhibitor Pp2, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 160 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/src+kinase+inhibitor/PP2/pmc10962971__pnas__2312290121__sapp-21-27-31
Average 95 stars, based on 160 article reviews
C Src Kinase Inhibitor Pp2, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 95/100, based on 160 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/src+kinase+inhibitor/PP2/pmc10962971__pnas__2312290121__sapp-21-27-31
Average 95 stars, based on 160 article reviews
c src kinase inhibitor pp2 - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Incubation:Article Title: CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation Article Snippet: .. For experiments with pharmacological inhibitors, macrophages were incubated with the following pharmacological inhibitors: Article Title: CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation. Article Snippet: For experiments with pharmacological inhibitors, macrophages were incubated with the following pharmacological inhibitors: Src kinase inhibitor, dasatinib; V-ATPase inhibitor, concanamycin D; actin polymerization inhibitor, cytochalasinD; protease inhibitor, leupeptin, and pepstatin A. Inhibitors were sourced from Selleckchem or Caymanchem and adjust to final concentration of 2 uM. .. For experiments with pharmacological inhibitors, macrophages were incubated with the following pharmacological inhibitors: Protease Inhibitor:Article Title: CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation Article Snippet: .. For experiments with pharmacological inhibitors, macrophages were incubated with the following pharmacological inhibitors: Article Title: CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation. Article Snippet: For experiments with pharmacological inhibitors, macrophages were incubated with the following pharmacological inhibitors: Src kinase inhibitor, dasatinib; V-ATPase inhibitor, concanamycin D; actin polymerization inhibitor, cytochalasinD; protease inhibitor, leupeptin, and pepstatin A. Inhibitors were sourced from Selleckchem or Caymanchem and adjust to final concentration of 2 uM. .. For experiments with pharmacological inhibitors, macrophages were incubated with the following pharmacological inhibitors: Concentration Assay:Article Title: CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation Article Snippet: .. For experiments with pharmacological inhibitors, macrophages were incubated with the following pharmacological inhibitors: Article Title: CAR macrophages with built-In CD47 blocker combat tumor antigen heterogeneity and activate T cells via cross-presentation. Article Snippet: For experiments with pharmacological inhibitors, macrophages were incubated with the following pharmacological inhibitors: Src kinase inhibitor, dasatinib; V-ATPase inhibitor, concanamycin D; actin polymerization inhibitor, cytochalasinD; protease inhibitor, leupeptin, and pepstatin A. Inhibitors were sourced from Selleckchem or Caymanchem and adjust to final concentration of 2 uM. .. For experiments with pharmacological inhibitors, macrophages were incubated with the following pharmacological inhibitors: |
